"primary breast tumors" trang 3 - tải miễn phí từ tailieunhanh
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways

Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
13    40    0
Determinants for non-sentinel node metastases in primary invasive breast cancer: A population-based cohort study of 602 consecutive patients with sentinel node metastases

Determinants for non-sentinel node metastases in primary invasive breast cancer: A population-based cohort study of 602 consecutive patients with sentinel node metastases
10    116    0
Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
9    49    0
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
9    66    1
Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: A 16-year retrospective review at the Douala general hospital, Cameroon

Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: A 16-year retrospective review at the Douala general hospital, Cameroon
9    60    1
Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs)

Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs)
17    72    1
Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results

Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results
7    55    1
Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers

Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers
8    53    1
Performance of ultrasonography screening for breast cancer: A systematic review and meta-analysis

Performance of ultrasonography screening for breast cancer: A systematic review and meta-analysis
15    50    1
Obesity impacts the regulation of miR-10b and its targets in primary breast tumors

Obesity impacts the regulation of miR-10b and its targets in primary breast tumors
10    32    1
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer
13    42    1
Diffuse cavernous hemangioma of the skull misdiagnosed as skull metastasis in breast cancer patient: One case report and literature review

Diffuse cavernous hemangioma of the skull misdiagnosed as skull metastasis in breast cancer patient: One case report and literature review
6    61    1
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions
14    77    1
A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer
11    32    1
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
13    68    1
Tumor slice culture system to assess drug response of primary breast cancer

Tumor slice culture system to assess drug response of primary breast cancer
13    62    1
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
8    63    1
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours

Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours
11    83    1
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients

Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
12    34    1
Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients

Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients
11    41    1